Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Experience Is standing by: History's Most noteworthy Travelers - 2When does Spotify Wrapped come out? The music streamer says 'soon.'
- 3The Best Portable Applications for Emotional wellness and Prosperity
- 4One ant for $220: the new frontier of wildlife trafficking
- 5Step by step instructions to Pick A Pre-owned vehicle Stage
- A Manual for the Right SUV for Seniors
- This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
- How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie
- Quantum Computing’s Next Major Breakthroughs Could Come From Australia
- NASA’s Artemis II mission will take an astronaut crew around the Moon – a space policy expert describes the long road to launch
- The most effective method to Settle on Informed Conclusions about Senior Insuranc.
- Witness the elegance of the cosmic butterfly in a remarkable telescope photo
